Stock Expert AI

Vertex Pharmaceuticals Incorporated (VRTX) Stock Forecast & Price Target

The FMP analyst consensus price target for VRTX is $579.29 (median $608.00; range $350.00 to $665.00), captured Nov 18, 2026. Coverage: 21 analysts contributing to the forward estimates (FMP), captured Nov 15, 2026.

VRTX analyst price target

Consensus (mean) target$579.29as of Nov 18, 2026
Median target$608.00as of Nov 18, 2026
High target$665.00as of Nov 18, 2026
Low target$350.00as of Nov 18, 2026

Source: FMP price-target consensus · Captured Nov 18, 2026.

Coverage: 21 analysts contributing to the forward estimates (FMP) · captured Nov 15, 2026.

Price and implied move

Last stored price$536.45as of Nov 18, 2026

The same stored quote the VRTX stock page shows, dated to its trading session.

Implied move to consensus (calculated): +8.0%

(Consensus $579.29, captured Nov 18, 2026, minus last stored price $536.45, as of the Nov 18, 2026 trading session) ÷ last stored price. Arithmetic on two stored figures, not a prediction.

Forward analyst estimates

Fiscal 2026 EPS estimate$18.16as of Nov 15, 2026
Fiscal 2026 revenue estimate$13.26Bas of Nov 15, 2026
Analysts in the fiscal 2026 estimate21as of Nov 15, 2026

Source: FMP analyst consensus estimates · Captured Nov 15, 2026.

Frequently asked questions

What is the VRTX price target?

The FMP analyst consensus price target for VRTX is $579.29 (median $608.00; range $350.00 to $665.00), captured Nov 18, 2026. Coverage: 21 analysts contributing to the forward estimates (FMP), captured Nov 15, 2026.

Is the VRTX consensus target pulled by outliers?

In FMP's consensus captured Nov 18, 2026, the mean (consensus) target for VRTX is $579.29 and the median is $608.00: the mean is 4.7% below the median, so lower targets pull the average down.

How far is the VRTX consensus target from the current price?

Against the last stored price of $536.45 (as of the Nov 18, 2026 trading session), the consensus implies a move of +8.0%. That figure is arithmetic on those two stored numbers, not a prediction. The target was captured Nov 18, 2026.

What do analysts expect for VRTX earnings?

Analysts expect fiscal 2026 EPS of $18.16 for Vertex Pharmaceuticals Incorporated (VRTX), according to FMP's consensus estimate captured Nov 15, 2026. The matching revenue estimate is $13.26B. The estimate reflects 21 contributing analysts.

Full VRTX stock analysis →

This is educational content, not investment advice. Past performance does not guarantee future results.